Clinical Trial: AGN-199201 for the Treatment of Erythema With Rosacea

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title:

Brief Summary: This study will evaluate the safety and efficacy of 3 doses of AGN-199201 once and twice daily compared to vehicle for the treatment of moderate to severe facial erythema associated with rosacea.